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Protein Kinase C-Dependent Upregulation of
miR-203 Induces the Differentiation of Human
Keratinocytes
Eniko¨ Sonkoly1,4, Tianling Wei1,4, Elizabeth Pavez Lorie`2, Hiroyuki Suzuki3, Mitsuyasu Kato3, Hans To¨rma¨2,
Mona Sta˚hle1 and Andor Pivarcsi1
Terminal differentiation of keratinocytes is a multistep process that requires a coordinated program of gene
expression. We aimed to explore the possible involvement of a previously unreported class of non-coding RNA
genes, microRNAs (miRNAs) in keratinocyte differentiation by using miRNA expression profiling. Out of 365
miRNAs tested, 7 showed significant change between keratinocytes cultured in low or high calcium
concentration. The highest-ranked upregulated gene was miR-203, whose expression was significantly
upregulated in response to calcium and other inducers of keratinocyte differentiation such as 12-O-
tetradecanoylphorbol-13-acetate (TPA) and vitamin D3. Differentiation-induced upregulation of miR-203
expression was blocked by treatment with specific inhibitors of protein kinase C (PKC), GF109203X, and
Ro31-8220. Moreover, our results showed that the activator protein-1 (AP-1) proteins c-Jun and JunB regulate
miR-203 expression in keratinocytes. In contrast to inducers of keratinocyte differentiation, epidermal growth
factor and keratinocyte growth factor suppressed miR-203 expression in keratinocytes below the basal level.
Overexpression of miR-203 in keratinocytes resulted in enhanced differentiation, whereas inhibition of miR-203
suppressed calcium-induced terminal differentiation as judged by involucrin expression. These results suggest
that upregulation of miR-203 in human keratinocytes is required for their differentiation and is dependent on
the activation of the PKC/AP-1 pathway.
Journal of Investigative Dermatology (2010) 130, 124–134; doi:10.1038/jid.2009.294; published online 17 September 2009
INTRODUCTION
MicroRNAs (miRNAs) are short, typically B22 to 23 nt long
non-coding RNA molecules that regulate the expression of
protein-coding genes at the post-transcriptional level by
interfering with translation of mRNAs or by inducing their
degradation (Lee and Ambros, 2001; Bartel, 2004; He and
Hannon, 2004). An interesting aspect of miRNA function is
that each miRNA potentially regulates hundreds of target
genes simultaneously (Baek et al., 2008). To date (March,
2009, miRBase 13.0) (Griffiths-Jones et al., 2006), 706
miRNA genes have been identified in the human genome
and their predicted number is around 1,000. It is estimated
that the majority of all protein-coding genes are subject to
miRNA-mediated regulation. Therefore, miRNAs are the most
abundant class of regulators of gene expression in the human
genome. To date, little is known about the expression and
regulation of miRNAs in human keratinocytes.
Intensive research in recent years showed that miRNAs
have pivotal functions in nearly all biological processes
investigated. miRNAs have been shown to regulate embryo-
nic development (Ambros, 2004), hematopoiesis (Chen et al.,
2004), cell proliferation and apoptosis (Croce and Calin,
2005), as well as several aspects of the immune response and
inflammation (Sonkoly et al., 2008; Sonkoly and Pivarcsi,
2009). A function for miRNAs in cell differentiation is firmly
established and has been shown in T cells (Wu et al., 2007),
hematopoietic cells (Shivdasani, 2006), embryonic stem cells
(Tzur et al., 2008), and osteoclasts (Sugatani and Hruska,
2009). miRNAs are also involved in skin development, as
evidenced by morphological changes in the skin of mice with
a conditional knockout of Dicer, an enzyme essential for
miRNA biogenesis (Yi et al., 2006). In particular, one miRNA,
miR-203, came into focus when our group identified it to be
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overexpressed in psoriasis and found that it has a unique
expression profile by being expressed at the highest level in
the skin for which it may be termed a ‘‘skin-specific miRNA’’
(Sonkoly et al., 2007). Within the major cellular constituents
of healthy human skin, miR-203 was exclusively expressed
by keratinocytes, suggesting a pivotal role for it in keratino-
cyte functions (Sonkoly et al., 2007). We found that miR-203
mediates the post-transcriptional suppression of Suppressor of
Cytokine Signaling-3 (SOCS-3), a negative regulator of the
JAK/signal transducer and activator of transcription (STAT)
pathway (Sonkoly et al., 2007). Interestingly, miR-203 was
not uniformly expressed in the healthy human epidermis, but
formed a gradient with low expression in the basal cell layer
and high expression in the more differentiated suprabasal layers
(Sonkoly et al., 2007). This expression pattern suggested its
involvement in keratinocyte differentiation. Compelling evi-
dence for this came in 2008 when two independent groups
showed that miR-203 induces cell-cycle exit and represses
‘‘stemness’’ in epidermal progenitors (Lena et al., 2008; Yi et al.,
2008). In accordance with human data, miR-203 was also
preferentially expressed in the suprabasal layers of healthy
mouse epidermis (Yi et al., 2008). Moreover, transgenic
overexpression of miR-203, driven by a keratin 14 promoter,
resulted in the formation of a thinner epidermis and decreased
proliferation, suggesting critical roles for miR-203 in epidermal
morphogenesis by restricting the proliferative capacity of
keratinocytes (Yi et al., 2008). Interestingly, miR-203 was found
to be downregulated in esophageal cancer (Feber et al., 2008).
Keratinocyte differentiation is a highly coordinated multi-
step process regulated by growth factors, autocrine and
paracrine intercellular signaling mechanisms and external
stimuli. Several factors have been described as differentiating
agents for keratinocytes in vitro and in vivo, such as calcium,
vitamin D, and 12-O-tetradecanoylphorbol-13-acetate (TPA)
(Hawley-Nelson et al., 1982; Pillai et al., 1990; Gibbs et al.,
1996). Calcium is the best characterized differentiation agent.
In vitro, increasing the extracellular calcium concentration
above 0.1 mM (calcium switch) leads to the expression of
differentiation-related genes and morphological changes
(Yuspa et al., 1989). The expression and function of most
miRNAs in human keratinocytes and during their differentia-
tion has not been explored.
We investigated the expression of miRNAs in a keratino-
cyte model of differentiation and identified miR-203 as the
most upregulated miRNA during keratinocyte differentiation.
Furthermore, we characterized the signal pathways involved
in the regulation of miR-203 and the functional consequence
of miR-203 dysregulation during keratinocyte differentiation.
RESULTS
Calcium-induced differentiation alters miRNA expression in
keratinocytes
To investigate whether calcium-induced differentiation of
keratinocytes affects miRNA expression, we carried out a
comprehensive analysis of miRNA expression in primary
human keratinocytes cultured under low-calcium (0.06 mM)
or high-calcium (1.5 mM) conditions. Using the TaqMan Low
Density Array (TLDA) platform, we analyzed the expression
of the mature, biologically active form of 365 human miRNAs
48 hours after calcium treatment. The 25 most abundant
miRNAs in proliferating and in differentiated keratinocytes
could be classified into several gene families: the miR-17
family (miR-20a, miR-19a and miR-19b, miR-92, and
miR-93), miR-221 family (miR-221 and miR-222), miR-26
family (miR-26a and miR-26b), miR-99 family (miR-99a and
miR-100), the miR-125 family (miR-125a and miR-125b), and
the miR-15 family (miR-15b and miR-16). In addition to these
miRNA families, miR-205, miR-200c, miR-31, miR-24, and
miR-21 were identified as particularly abundant miRNAs in
both undifferentiated and differentiated human keratinocytes
(Figure 1a and b). Moreover, miR-203 was among the
abundant miRNAs in differentiated but not in undifferentiated
keratinocytes (Figure 1b).
Comparing the miRNA expression profile between low-
calcium-grown and high-calcium-grown keratinocytes using
the significance analysis of microarrays (SAM), we identified
five miRNAs (miR-203, miR-429, miR-98, miR-200a, and
miR-365) to be upregulated and two miRNAs (miR-200c
and miR-210) to be downregulated (Figure 1c). Interestingly,
the miRNA showing the highest upregulation was miR-203, a
miRNA that we previously identified to be preferentially
expressed in the skin out of 21 human organs analyzed and
shown to be expressed specifically by keratinocytes among
the cellular constituents of the skin (Sonkoly et al., 2007).
miR-203 was upregulated 8.3-fold in high-calcium-grown
keratinocytes compared with low-calcium-grown controls
(Figure 1c–e). Involucrin, an early marker of keratinocyte
terminal differentiation known to be induced by calcium
treatment (Watt, 1983), was upregulated 6.9-fold in
high-calcium-grown compared with low-calcium-grown
keratinocytes (Figure 1f), indicating that differentiation was
indeed induced in high-calcium-treated samples.
miR-203 is upregulated during calcium- and TPA-induced
keratinocyte differentiation
As miR-203 showed the highest upregulation in high-
calcium-treated keratinocytes, we next focused on character-
izing the regulation of miR-203 by agents that are known to
affect keratinocyte functions. First, we aimed to analyze the
kinetics of miR-203 upregulation after treatment with calcium
and another known inducer of keratinocyte differentiation,
the phorbol ester TPA (Hawley-Nelson et al., 1982) in time-
course experiments. To this end, we treated keratinocytes
with calcium or TPA for 1, 4, 24, and 48 hours, monitored
morphological changes in the cell cultures, and measured
miR-203 expression by miRNA-specific quantitative real-time
PCR (Figure 2a and b). After 24–48 hours of treatment with
TPA or calcium, keratinocytes showed morphological signs of
terminal differentiation (data not shown). miR-203 expression
was significantly (Po0.05) induced 24 hours after exposure
of keratinocytes to high calcium (Figure 2a). We observed
further upregulation of miR-203 48 hours after calcium
treatment (Figure 2a). Stimulation with TPA resulted in a
detectable and significant (Po0.01) upregulation of miR-203
expression already after 4 hours, and this effect was even
stronger 24 and 48 hours post treatment (Figure 2b). These
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results showed that the upregulation of miR-203 expression in
differentiating keratinocytes is not specific for calcium-
induced differentiation but can also be achieved by other
inducers of keratinocyte differentiation.
miR-203 is upregulated by vitamin D in human keratinocytes
Next, we aimed to investigate whether vitamin D, which
induces keratinocyte differentiation through a different path-
way, regulates miR-203 expression. To determine possible
early and late effects, we treated keratinocytes with vitamin
D3 (1,25(OH)2D3) for 3, 6, 12, 24, and 48 hours and analyzed
the expression of miR-203 and a positive control gene known
to be directly regulated by vitamin D3, hCAP18 (Weber et al.,
2005). In accordance with literature data, vitamin D3 induced
hCAP18 expression in a time-dependent manner. hCAP18
mRNA levels were significantly (Po0.01) increased as early
as 3 hours after treatment, and this induction was even
stronger at 6, 12, 24, and 48 hours post treatment (Figure 2c).
In comparison, quantitative real-time PCR results showed
significantly increased miR-203 expression only after 24
(Po0.001) and 48 hours after vitamin D3 treatment
(Po0.001) (Figure 2d).
Cell density regulates miR-203 expression in human
keratinocytes
To further investigate the regulation of miR-203 expression in
keratinocytes, we set out to measure miR-203 levels in
monolayer keratinocyte cultures at different cell densities. As
cultures grew to confluence, cells became tightly packed,
maintained epithelial morphology, and close association to
one another, eventually establishing close contacts as a large
continuous monolayer sheet of cells. After confluence, cells
became stratified and few mitoses were observed. We chose
to determine the expression of involucrin as a marker for the
differentiation stage of keratinocytes in this model system.
Involucrin expression began to increase when cells reached
confluence and showed a more than six-fold increase in cells
that are kept confluent for 4 days (Figure 2e). In accordance
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Figure 1. MicroRNA expression profiling in proliferating and differentiated keratinocytes. Primary human keratinocytes were cultured in the presence of
1.5 mM CaCl2 (n¼ 3, high calcium) or low-calcium medium (n¼ 3, low calcium) for 48 hours, and miRNA expression was analyzed using TaqMan Low
Density Array. (a) Relative abundance of miRNAs in low-calcium-grown keratinocytes. The 25 most abundant miRNAs and U48 (RNU48) are shown. Data are
expressed in relative units (RU) compared with U48 RNA. (b) Relative abundance of miRNAs in high-calcium-grown keratinocytes. The 25 most abundant
miRNAs and the housekeeping small nucleolar RNA U48 (RNU48) are shown. (c) Differentially expressed miRNAs in high-calcium-grown keratinocytes
versus low-calcium-grown keratinocytes according to the SAM algorithm (fold change 41.5, qo20%). (d) Relative abundance of miRNAs in keratinocytes
treated with high calcium and fold change of miRNAs in high-calcium-grown keratinocytes versus low-calcium-grown keratinocytes. (e) The expressions of
involucrin and miR-203 were analyzed using quantitative real-time PCR in low-calcium-grown and high-calcium-grown keratinocytes. Data are expressed in
RU compared with 18S RNA and U48 RNA, respectively.
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with our previous results, miR-203 was expressed already at
low cell densities at a relatively high level in keratinocytes. We
observed more than 10-fold increase in miR-203 expression in
cells that are kept in confluence for 4 days, compared with
subconfluent keratinocytes (Figure 2f). These results further
confirmed the notion that miR-203 expression is tightly linked
to the differentiation program in keratinocytes.
EGF and KGF suppress miR-203 expression in keratinocytes
Next, we aimed to study whether growth factors that maintain
keratinocytes in an undifferentiated, proliferative state can
regulate miR-203 expression. To this end, primary human
keratinocytes were treated with recombinant human epider-
mal growth factor (EGF) or keratinocyte growth factor (KGF)
or medium for 24 and 48 hours and miR-203 expression was
analyzed (Figure 2g). Quantitative real-time PCR results
showed a significant (Po0.001), 2.4-fold decrease in miR-
203 expression 24 hours after treatment with KGF (Figure 2g).
Similar to KGF, we observed a significant, 1.8-fold (Po0.05)
decrease in miR-203 expression in keratinocytes treated with
EGF for 24 hours (Figure 2g). The suppressive effect of EGF on
miR-203 expression in keratinocytes was more pronounced
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Figure 2. Inducers of keratinocyte differentiation upregulate, whereas growth factors suppress miR-203 expression. (a) The expression of miR-203 was
analyzed using quantitative real-time PCR in keratinocytes treated with CaCl2 or medium. (b) The expression of miR-203 was analyzed using quantitative
real-time PCR in keratinocytes treated with TPA or DMSO. (c and d) Primary human keratinocytes were cultured in the presence or absence of vitamin D3 for 3,
6, 12, 24 or 48 hours. The expressions of hCAP18 (c) and the functionally active, mature form of miR-203 (d) were analyzed using quantitative real-time PCR.
(e and f) Primary human keratinocytes were analyzed when 25% confluent, 50% confluent (pre-confluent), 100% confluent, and 4 days after reaching
confluence (post-confluent, 100%þ4 days). The expressions of involucrin (e) and the functionally active, mature form of miR-203 (f) were analyzed using
quantitative real-time PCR. Data are expressed as relative units (RU) compared with the 25% confluence culture. (g) Primary human keratinocytes were cultured
in the presence or absence of epidermal growth factor (EGF; 10 ng ml1) or keratinocyte growth factor (KGF; 20 ng ml1) for 24 and 48 hours. The expression of
the functionally active, mature form of miR-203 was analyzed using quantitative real-time PCR. The expression of miR-203 was normalized to U48 RNA,
and the expression of hCAP18 and involucrin was normalized to 18S RNA. Data are expressed as RU. Means±SD of three independent experiments are shown.
*Po0.05, **Po0.01, and ***Po0.001.
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48 hours after treatment (Po0.05; 7.1-fold decrease) (Figure 2g).
Moreover, KGF treatment significantly (Po0.05; 8.1-fold)
suppressed miR-203 48 hours after treatment (Figure 2g).
These results show that KGF and EGF suppress miR-203
expression in keratinocytes.
In addition to differentiation- and proliferation-inducing
agents, we also analyzed the regulation of miR-203 expres-
sion by cytokines and microbial compounds known to
modulate keratinocyte functions. MiR-203 expression was
not regulated by any of the cytokines or microbial
compounds tested (Supplementary Figure S1a and b).
Activation of protein kinase C is required for differentiation-
induced upregulation of miR-203 expression
Next, we sought to explore the signal transduction pathways
involved in the differentiation-induced regulation of miR-203
in keratinocytes. TPA-induced terminal differentiation of
keratinocytes is mediated by the activation of protein kinase
C (PKC) (Yuspa et al., 1982). In vitro, PKC inhibitors
effectively block the terminal differentiation program induced
by calcium or TPA in keratinocytes (Dlugosz and Yuspa,
1993). Therefore, we set out to investigate whether the
induction of miR-203 during keratinocyte differentiation is
dependent on PKC signaling by measuring miR-203 expres-
sion in primary human keratinocytes treated with specific
PKC inhibitors, GF109203X and Ro31-8220, together with
TPA or DMSO alone (Figure 3a).
At 24 hours after administration of TPA, keratinocytes
formed dendritic structures, became elongated with spindle-
like phenotype or prominent cell rounding, all of which were
reversed by treatment with the specific PKC inhibitors (data
not shown). Quantitative real-time PCR results showed a
significant upregulation of involucrin expression, which was
equally reversed by both PKC inhibitors (Figure 3a). More-
over, TPA treatment induced a fivefold, significant (Po0.001)
increase in the expression of miR-203 in comparison with
DMSO-treated cells 24 hours after treatment (Figure 3a).
Treatment of keratinocytes with the specific PKC inhibitor,
GF109203X, not only significantly (Po0.001) blocked TPA-
induced miR-203 expression but also suppressed it to below
the basal level (Figure 3a). Similar to GF109203X, another
specific inhibitor of PKC, Ro31-8220, significantly (Po0.001)
inhibited TPA-induced miR-203 expression (Figure 3a).
A downstream target for PKC action in keratinocytes is
activator protein-1 (AP-1), which is a transcription factor
consisting of homodimers or heterodimers of the Jun and Fos
families of nuclear proteins (Rutberg et al., 1996; Shaulian and
Karin, 2001). AP-1 proteins have essential roles in the
regulation of keratinocyte growth and differentiation, although
different members of the AP-1 family can have antagonistic
effects. While c-Jun is primarily a positive regu-
lator of proliferation, JunB suppresses proliferation and
promotes differentiation (Shaulian and Karin, 2001; Zenz and
Wagner, 2006; Ikebe et al., 2007). To explore the regulation of
Jun family members by TPA in primary keratinocytes, we
measured JunB and c-Jun activity in TPA-treated keratinocytes
using transcription factor assays. TPA treatment led to
significantly increased JunB activation (Po0.05, Figure 3b),
which was prevented by the PKC inhibitors GF109203X and
Ro31-8220 (Po0.001 and Po0.01, respectively, Figure 3b). In
contrast to JunB, the activation of c-Jun was decreased in TPA-
treated keratinocytes (Po0.01, Figure 3c), and this decrease
was prevented by GF109203X (Po0.05, Figure 3c) but not by
Ro31-8220 (Figure 3c).
The AP-1 transcription factor complex is involved in the
regulation of miR-203
To investigate whether TPA-induced changes in the activity
of AP-1 proteins can have an effect on miR-203 expression,
we analyzed miR-203 expression in HaCaT keratinocytes
stably overexpressing c-Jun, or a dominant-negative mutant
of JunB, JunBDN (Ikebe et al., 2007). In HaCaT-JunBDN cell
lines (JunBDN6 and JunBDN8), miR-203 expression was
suppressed compared with mock-transfected HaCaT cells
(Figure 3d), suggesting that JunB is a positive regulator of miR-
203 expression. Moreover, in c-Jun-overexpressing HaCaT
cell lines, miR-203 was suppressed compared with mock
transfectants (Figure 3e), suggesting that c-Jun is a negative
regulator of miR-203 expression. Hence, reduced JunB or
increased c-Jun activity led to decreased miR-203 expression
in HaCaT keratinocytes, indicating the involvement of AP-1
in the regulation of miR-203.
Overexpression of miR-203 induces keratinocyte differentiation
To explore whether miR-203 has a functional role in
keratinocyte differentiation, we transiently overexpressed
miR-203 in primary keratinocytes by transfection of the
precursor molecule of miR-203 (pre-miR-203), and analyzed
the expression of involucrin in the transfected cells.
Immunofluorescence (Figure 4a) as well as western blot
(Figure 4b) analyses showed the upregulation of involucrin in
miR-203-overexpressing keratinocytes compared with those
transfected with a scrambled control, indicating that over-
expression of miR-203 induces differentiation of keratino-
cytes also in the absence of calcium or TPA.
Inhibition of miR-203 suppresses calcium-induced keratinocyte
differentiation
Next, we investigated the effect of miR-203 inhibition on
keratinocyte differentiation. To this end, we transfected
keratinocytes with locked nucleic acid (LNA) antagomirs
specific for miR-203 (anti-miR-203) or nonspecific scrambled
control LNA antagomir (anti-miR CON) and subsequently
treated the cells with calcium. Knockdown of miR-203 by
antagomir resulted in decreased involucrin expression after
calcium treatment, in comparison with controls, as shown by
immunofluorescence (Figure 4c) and western blotting (Figure
4d). These results suggest that miR-203 expression is required
for keratinocyte differentiation.
DISCUSSION
In this study, we identified the typical miRNA signature of
proliferating, undifferentiated (cultured in low calcium), and
differentiated (cultured in high calcium) human keratinocytes
and also identified miR-203 as a regulator of human
keratinocyte differentiation.
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Interestingly, the most abundant miRNAs in human
keratinocytes could be classified into several gene families
sharing 50 seed sequences (the highly conserved 7- or 8-mer
sequence within a miRNA that establishes target specificity).
Expressing multiple miRNAs with shared seed sequences may
enable the suppression of miRNA targets more effectively and
rapidly. Moreover, it may ensure that mutation of one miRNA
gene will not have detrimental effect on cells as other family
members may compensate for the loss of function. In addition
to the coordinated expression of these gene families, miR-
205, miR-200c, miR-31, miR-24, and miR-21 were identified
as particularly abundant miRNAs in human keratinocytes. To
date, virtually nothing is known about the roles of most of
these miRNAs in keratinocytes. Thus, investigation of the
function of these highly expressed miRNAs will be very
relevant to keratinocyte biology.
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Figure 3. miR-203 expression during keratinocyte differentiation is dependent on protein kinase C (PKC) activity and is regulated by the AP-1 transcription
factor complex. (a) The expression of involucrin (left panel) and miR-203 (right panel) in human keratinocytes cultured in the presence of DMSO (control),
phorbol ester TPA, TPAþGF109203X, or TPAþRo31-8220. The expression of involucrin was analyzed using quantitative real-time PCR and expression
data were normalized to 18S RNA. The expression of the functionally active, mature form of miR-203 was analyzed using quantitative real-time PCR. Expression
data were normalized to U48 RNA. Mean±SD of three independent experiments is shown. (b and c) Nuclear extracts were prepared from keratinocytes
treated with DMSO, TPA, TPAþGF109203X, or TPAþRo31-8220, and (b) JunB- or (c) c-Jun-dependent AP-1 DNA-binding activity was measured using
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**Po0.01, ***Po0.001.
www.jidonline.org 129
E Sonkoly et al.
MicroRNAs in Keratinocyte Differentiation
Out of 365 miRNAs analyzed, miR-203 was the most
upregulated by keratinocyte differentiation. In addition to
calcium, miR-203 expression was upregulated by other
inducers of keratinocyte differentiation such as TPA, high
cell density, and vitamin D3 (Hawley-Nelson et al., 1982).
The induction of miR-203 during keratinocyte differentiation
is in line with the expression pattern previously reported by
us, where miR-203 was mainly expressed by keratinocytes in
the suprabasal layers in the epidermis of healthy human skin
(Sonkoly et al., 2007).
Using TPA-induced keratinocyte differentiation as a
model, we showed that activation of PKC is required for
differentiation-induced upregulation of miR-203 in keratino-
cytes. Two specific PKC inhibitors (Toullec et al., 1991;
Cuenda and Alessi, 2000) suppressed miR-203 expression
below the basal level, suggesting that endogenous PKC
activation is required for homeostatic miR-203 expression. A
downstream target for PKC action in keratinocytes is the AP-1
transcription factor (Rutberg et al., 1996), which is composed
of the Jun and Fos family of nuclear proteins (Zenz and
Wagner, 2006). AP-1 activity has been shown to have
essential roles in the regulation of keratinocyte growth and
differentiation (Zenz et al., 2005; Zenz and Wagner, 2006).
We here show that TPA treatment of primary keratinocytes
increases the activity of JunB, whereas it suppresses c-Jun
activation, in accordance with previous data showing
differential effects of different AP-1 components: JunB has
been shown to suppress proliferation and promotes differ-
entiation of keratinocytes, whereas c-Jun is a positive
regulator of proliferation (Welter and Eckert, 1995; Zenz
and Wagner, 2006; Ikebe et al., 2007). Analysis of the
putative promoter region of the miR-203 gene showed the
presence of an AP-1 transcription factor-binding site (unpub-
lished observation), suggesting that AP-1 is directly involved
in the transcriptional regulation of miR-203. Our results
showed that in stably transfected HaCaT keratinocytes, both
suppression of JunB and the overexpression of c-Jun
decreased miR-203 expression, suggesting that JunB is a
positive whereas c-Jun is a negative regulator of miR-203
expression, which is in line with their antagonistic roles in
keratinocyte functions. In conclusion, our results suggest that
differentiation-induced miR-203 upregulation is dependent
on the activation of PKC and an altered balance between
AP-1 family members (Figure 5).
Previously, we identified miR-203 to be significantly
overexpressed in psoriasis in comparison with healthy skin
and atopic eczema (Sonkoly et al., 2007). As psoriasis is
characterized by hyperproliferation and disturbed differentia-
tion, one may expect decreased levels of miR-203 during
differentiation; which is clearly not the case. However,
psoriasis keratinocytes do not show an undifferentiated
(basal) phenotype but undergo an alternative differentiation
program and early terminal differentiation markers such as
involucrin are indeed overexpressed (Bernard et al., 1985).
In contrast to differentiation-inducing agents, the growth
factors EGF and KGF suppressed the expression of miR-203.
Both EGF and KGF have profound effects on keratinocytes.
Interestingly, growth factors also modulate the PKC/AP-1
pathway (Sharma et al., 2007), suggesting that this pathway
might not only be involved in the induction of miR-203 by
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Figure 4. Overexpression of miR-203 induces keratinocyte differentiation, whereas inhibition of miR-203 suppresses calcium-induced keratinocyte
differentiation. (a and b) Normal human keratinocytes cultured in low-calcium medium were transfected with a synthetic precursor molecule for miR-203
(pre-miR-203) or scrambled oligos as negative control (pre-miR-CON). (a) The expression of involucrin was visualized by immunofluorescent staining (red color)
in the keratinocytes 96 hours after transfection. Cell nuclei were visualized by DAPI (blue color). Bar¼ 100mm. (b) Western blotting was used to analyze
the expression of involucrin in the keratinocytes 96 hours after transfection with pre-miR-203 or pre-miR-CON. (c and d) Primary human keratinocytes were
transiently transfected with a specific miR-203 inhibitor (anti-miR-203) or a scrambled inhibitor (anti-miR-CON) and treated with 1.5 mM calcium for 72 hours.
(c) The expression of the keratinocyte-specific differentiation marker involucrin was visualized by immunofluorescent staining (red color) 72 hours after calcium
treatment. Cell nuclei were visualized by DAPI (blue color). Bar¼ 100mm. (d) The expression of involucrin was measured by western blotting.
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differentiation but also in its suppression by growth factors.
Our finding showing the suppression of miR-203 by EGF and
KGF identifies a previously unknown pathway by which
growth factors affect keratinocyte functions. Investigations of
miRNA-mediated effects of growth factors may represent a
previously unreported line of research in keratinocyte
biology.
Previously, we observed that miR-203 has a unique
expression pattern among miRNAs and can be termed a
‘‘skin-specific’’ miRNA (Sonkoly et al., 2007). Within the
major cellular constituents of healthy human skin, miR-203
was expressed only by keratinocytes in relevant quantities
(Sonkoly et al., 2007). This suggested that miR-203 has a skin-
and/or keratinocyte-specific function. We here show that
overexpression of miR-203 in human keratinocytes promotes
their differentiation even in the absence of other differentiat-
ing agents, as evidenced by increased involucrin expression.
Furthermore, our data show that inhibition of endogenous
miR-203 using antagomirs can suppress calcium-induced
keratinocyte differentiation, suggesting that miR-203 upregu-
lation is required for complete keratinocyte differentiation.
Although overexpression of miR-203 led to increased
involucrin expression, this effect is likely to be indirect, as
miRNAs have negative effects on protein output and because
there are no predicted binding sites for miR-203 in the 30-UTR
of involucrin mRNA (unpublished observation). We hypothe-
size that miR-203-induced involucrin expression is mediated
by miR-203 targets that have negative effects on differentia-
tion (Figure 5). Overexpression of miR-203 would eventually
lead to the post-transcriptional suppression of these genes,
which in turn would allow keratinocyte differentiation
(Figure 5). To date, SOCS-3 and p63 have been identified
as direct targets of miR-203 (Sonkoly et al., 2007; Yi et al.,
2008). However, additional target genes that may serve
as a link between miR-203 and differentiation still await
discovery.
Recently, Yi et al. (2008) found that transgenic mice
overexpressing miR-203 driven by keratin 14 promoter had a
thinner epidermis with lower p63 expression in comparison
with wild-type mice. Moreover, transgenic mouse keratino-
cytes overexpressing miR-203 had a reduced proliferation
rate and reduced colony-forming capacity in comparison
with wild-type keratinocytes (Yi et al., 2008). However,
epidermal differentiation markers were not induced by
overexpression of miR-203 as judged by the expression of
K10, Filaggrin, and Loricrin mRNAs (Yi et al., 2008). In
contrast, we found that ectopic overexpression of miR-203
led to increased keratinocyte differentiation judged by
involucrin protein level. Moreover, inhibition of endogenous
miR-203 impaired calcium-induced increase of involucrin
protein. Further investigation and probably the identification
of additional miR-203 targets will be necessary to determine
whether differences between these observations are due to
different methods and markers used (the measurement of
gene expression at the protein or mRNA level, the use of
different differentiation markers, the use of synthetic miRNA
precursors instead of viral vectors, the use of antagomir
controls) or perhaps can be attributed to the expression of a
different set of targets in human and mouse. Although miR-
203 is highly conserved between mice and humans, this does
not necessarily imply that all of their targets are conserved as
it is indicated by the obvious differences between the human
and the mouse epidermis.
Taken together, our results identify miR-203 as the most
upregulated miRNA during keratinocyte differentiation.
Moreover, we show that the differentiation-induced upregu-
lation of miR-203 is dependent on the activation of the PKC/
AP-1 pathway. In contrast, growth factors suppressing the
keratinocyte differentiation program suppress miR-203
expression below the basal level, and one can hypothesize
that this suppression may be required for their function.
Furthermore, our results show that upregulation of miR-203
in human keratinocytes is required for their differentiation.
MATERIALS AND METHODS
miRNA expression profiling
miRNAs were reverse transcribed and amplified (PCR) using the
multiplex reverse transcription (RT) TaqMan MicroRNA Low Density
Array (TLDA) (Applied Biosystems, Foster City, CA). An amount of
640 ng of starting total RNA (80 ng for each of the eight RT-PCR) was
used for each sample. The global miRNA profiling for 365 human
miRNAs was carried out using the TaqMan LDA Human microRNA
Panel v1.0 (MicroFluidic card, Applied Biosystems). TLDAs were run
on the ABI7900 HT analyzer with TLDA upgrade and analysed with
RQ Manager software provided by Applied Biosystems. All the
quality control tests were validated: blanks and reproducibility
(standard deviation of cycle threshold (CT) o1) of the two small
nucleolar housekeeping RNAs RNU48 (SNORD48) and RNU44
Ca2+
TPA
Protein kinase C
JunB
c-Jun
AP-1 complex
miR-203
p63, SOCS-3
and other targets
Differentiation
Figure 5. A proposed model for the regulation and role of miR-203 in
keratinocyte differentiation. Differentiation-inducing stimuli (TPA and
calcium) activate PKC and lead to an altered balance between AP-1 proteins
(JunB and c-Jun) and increased miR-203 expression in keratinocytes. miR-203
induces keratinocyte differentiation through post-transcriptional suppression
of its target mRNAs (p63, SOCS-3, and yet-unidentified targets).
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(SNORD44). The amount of RNA from each sample was calibrated
to the more stable (between the different arrays) small nucleolar
housekeeping RNA, RNU48. To find consistently differentially
expressed genes, the data were subjected to SAM analysis as
described (Sonkoly et al., 2007). Genes showing at least 1.5-fold
regulation and a q-valueo20% were considered to be differentially
expressed.
Cells and transfections
Human adult skin epidermal keratinocytes (obtained from Cascade
Biologics, Portland, OR) were cultured in EpiLife serum-free
keratinocyte growth medium including Human Keratinocyte Growth
Supplement at a final Ca2þ concentration of 0.06 mM (Cascade
Biologics). Third passage keratinocytes were used at 50–70%
confluence for all experiments, except when assessing cell-density-
dependant miR203 expression.
To investigate the effects of miR-203 on keratinocyte differentia-
tion, human keratinocytes at 70% confluence were transfected with
10 nM Pre-miR 203 miRNA Precursor (Ambion, Foster City, CA),
10 nM Pre-miR miRNA Precursor Negative Control #1 (Ambion),
5 nM LNA-based miR-203 inhibitor (Santaris Pharma, Hoersholm,
Denmark), or 5 nM Universal LNA-based negative control (Santaris
Pharma) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA),
following the manufacturer’s instruction. The expression of the
mature, biologically active form of miR-203 in transfected keratino-
cytes was confirmed by real-time PCR. In the inhibitor experiments,
the cells were exposed to 1.5 mM CaCl2 (Cascade Biologics) after
16 hours. Transfection with anti-miR-203 prevented calcium-in-
duced upregulation of endogenous miR-203 as evidenced by the
results of real-time PCR analysis. At 72–96 hours post-transfection,
the cells were assayed for involucrin protein expression by western
blotting and immunofluorescence. HaCaT keratinocytes were
cultured and transfected with JunBDN and c-Jun construct as
previously described (Ikebe et al., 2007).
Keratinocyte differentiation models
To investigate the effects of keratinocyte differentiation inducers in
regulating miRNAs expression, keratinocytes were subcultured into
six-well plates at a density of 24,000 cells per well and exposed to
1.5 mM CaCl2 (Cascade Biologics), 50 ng ml
1 TPA, and 100 nM
vitamin D3 (1,25(OH)2D3) (both from Sigma, St Louis, MO). Medium
was used as a control for CaCl2, and DMSO was used as a control for
TPA and for vitamin D3. Plates to be used for RNA preparation, real-
time PCR, and LDA profiling (Applied Biosystems) were washed
twice with phosphate-buffered saline (PBS) at 1, 4, 24, and 48 hours
after calcium and TPA treatment, and at 3, 6, 12, 24, and 48 hours
after vitamin D3 treatment. To avoid effects of changes in
keratinocyte physiology during culture, each time point includes
treated and corresponding untreated, control samples. To examine
whether confluent status of keratinocytes influences miR-203
expression, RNA were collected from the cells at 25, 50, and
100% confluence and at 4 days after confluence.
PKC inhibitors, growth factors, and cytokines
Two PKC inhibitors, 100 nM Ro31-8220 (Calbiochem, Darmstadt,
Germany) and 10 mM GF109203X (Calbiochem) were applied to
keratinocytes, followed by 50 ng ml1 TPA stimulation. The cells
were washed with PBS twice after 24 hours and approached to RNA
extraction. To explore regulation of growth factors and cytokines in
miR-203 expression, cells were treated with 10 ng ml1 EGF (Sigma)
and 20 ng ml1 KGF (Sigma), and harvested 24 or 48 hours after
treatment. Furthermore, keratinocytes were treated with IL-4
(50 ng ml1), IFN-g (50 ng ml1), GM-CSF (50 ng ml1), IL-6
(100 ng ml1), lipopolysaccharide (1 mg ml1; Sigma), or zymosan
(80 mg ml1; Sigma) for 4 or 24 hours, or left untreated. Moreover,
keratinocytes were treated with 50 ng ml1 tumor necrosis factor-a
for 1, 4, 24, or 48 hours, or left untreated. All cytokines were
purchased from R&D Systems (Minneapolis, MN, USA).
RNA extraction and RT
Total RNA was prepared using Trizol (Invitrogen). The RNA
concentration was determined by spectrophotometry. Total RNA
(1.0 mg) was reversed transcribed into cDNA in a 20-ml reaction by
RevertAid First Strand cDNA Synthesis Kit (Fermentas, Burlington,
CA). The resulting cDNA was diluted with 80 ml dH2O to obtain a
concentration of 10 ng ml1 cDNA.
Quantitative real-time PCR
Quantification of miRNAs by TaqMan Real-Time PCR was carried
out as described by the manufacturer (Applied Biosystems). Briefly,
80 ng of template RNA was reverse transcribed using the TaqMan
MicroRNA Reverse Transcription Kit and the multiplex RT primer
pools containing miRNA-specific stem-loop primers (Applied
Biosystems). Diluted RT product (1.5 ml) was introduced into the
20-ml PCR reactions, which were incubated in 384-well plates on the
ABI 7900HT thermocycler (Applied Biosystems) at 95 1C for
10 minutes, followed by 40 cycles of 95 1C for 15 seconds and
60 1C for 1 minute. Target gene expression was normalized between
different samples based on the values of U48 small nucleolar RNA
expression.
For the quantification of involucrin, 20 ng of cDNA was amplified
per reaction in the presence of SYBR green master mix, (Applied
Biosystems) and the following specific primers: involucrin—F: 50-AC
CCATCAGGAGCAAATGAAA-30 and R: 50-GCTCGACAGGCACCTT
CTGGCA-30 (Stage 1: 95 1C for 5 minutes, stage 2: 95 1C for
15 seconds, 60 1C for 1 minute, repeated 40 times, stage 3: 95 1C
for 1 minute, stage 4: 55 1C for 1 minute; stage 5: 55 1C for
10 seconds, increasing the set point temperature after cycle 2 by
0.5 1C, repeated 80 times). For the quantification of hCAP18, 20 ng
of cDNA was amplified per reaction in the presence of TaqMan
universal master mix (Applied Biosystems) and the following specific
primers and probe: 50-GTCACCAGAGGATTGTGACTTCAA-30
and 50-TTGAGGGTCACTGTCCCCATA-30 for the primers, and
6-FAM–50-CCGCTTCACCAGCCCGTCCTT-30–BHQ1 for the fluoro-
genic probe. Gene-specific PCR products were measured by means
of an ABI PRISM 7000 Sequence Detection Systems (Applied
Biosystems) (stage 1: 50 1C for 2 minutes; stage 2: 95 1C for
10 minutes; and stage 3: 95 1C for 15 seconds, 60 1C for 1 minute,
repeated 40 times). Target gene expression was normalized based on
the values of the expression of 18S RNA (18S-F: 50-CGGCTACCA
CATCCAAGGAA-30 and 18S-R: 50-GCTGGAATTACCGCGGCT-30;
18S TaqMan probe: 50-FAM/TGCTGGCACCAGACTTGCCCTC-30).
Western blotting
Keratinocyte lysates were analyzed for protein expression by western
blotting with anti-human involucrin antibody at a concentration of
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1:1,000 (Sigma Aldrich, St Louis, MO). The protein levels were
visualized by ECL (GE Healthcare, Niskayuna, NY) using horseradish
peroxidase-conjugated Protein A/G (Pierce Chemical and Thermo
Fisher Scientific, Waltham, MA).
Immunofluorescence
Upon harvest, the cells were washed in PBS, followed by 10 minutes
fixation in 4% formaldehyde and 5 minutes blocking in serum-free
protein block (Dako, Denmark) at room temperature. The primary
antibody (anti-human involucrin antibody, Sigma Aldrich) diluted at
1:200 in 1%BSA/PBS was added and incubated overnight. The
secondary antibody, 1mg ml1 Alexa Fluor 594 donkey anti-mouse
IgG (Invitrogen), was diluted in 1%BSA/PBS and incubated with
the cells for 17 minutes at room temperature without exposing to
direct light. Sections were mounted using 40-6-diamidino-2-pheny-
lindole (DAPI)-containing mounting medium (Vector Laboratories,
Burlington, CA).
AP-1 transcription factor assay
To examine the involvement of the AP1 transcription factor complex
in the regulation of miR-203, keratinocytes were cultured in 60 mm
Petri dishes at a density of 50,000 cells per well and cultured in
EpiLife serum-free keratinocyte growth medium excluding Human
Keratinocyte Growth Supplement when reaching to 70% conflu-
ence. One day after starvation, 100 nM Ro31-8220 (Calbiochem) or
10 mM GF109203X (Calbiochem) were added to keratinocytes,
followed by 50 ng ml1 TPA stimulation. The nuclear fraction was
extracted by nuclear extract kit (Active Motif, Carlsbad, CA), and
activation of JunB and c-Jun were measured using the TransAM AP-1
Family Transcription Factor Assay Kit (Active Motif) according to the
manufacturer’s instruction.
Statistical analysis
In the analysis of the TLDA data, differentially expressed genes were
identified by were subjecting data to SAM analysis as described
(Sonkoly et al., 2007). Genes showing at least 1.5-fold regulation
and a q-valueo20% were considered to be differentially expressed.
Using Student’s t-test, statistical differences between means of
quantitative real-time PCR and transcription factor assay data
was determined. A P-value o0.05 was considered statistically
significant.
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